Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OsteoCool Tumor Ablation Post-Market Study (OPuS One)

NCT03249584 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT03249584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03249584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OsteoCool Tumor Ablation Post-Market Study (OPuS One)
Lead sponsor
MedtronicNeuro
Phase
Not applicable
Overall status
Completed
Start date
October 12, 2017
Completion date
July 17, 2020
Enrollment
218 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

metastasis spine, metastasis to bone